Using a structured medical note for determining the safety profile of anthrax vaccine for US soldiers in Korea.
Selected military personnel are immunized with an FDA-licensed anthrax vaccine unless there are clinical contraindications. The objective of this analysis is to capture the experience of soldiers receiving anthrax vaccine to assist in better patient-provider communication and clarify the safety profile of the vaccine in this population as a quality-assurance initiative. Between August 1998 and July 1999, 2824 soldiers immunized against anthrax at one military clinic completed a structured medical note that was reviewed by a clinician. Female gender, prior vaccine-associated adverse events, and medication use were significantly related to higher reports of adverse events. All reported immediate consequences resolved.
D000328:Adult; D000704:Analysis of Variance; D022122:Anthrax Vaccines / Q000009:adverse effects*; D004282:Documentation; D004347:Drug Interactions; D005260:Female; D006304:Health Status; D006801:Humans; D007723:Korea; D016015:Logistic Models; D008297:Male; D008889:Military Personnel; D011356:Product Labeling; D012727:Sex Characteristics; D014481:United States; D014611:Vaccination / Q000009:adverse effects*
D022122:Anthrax Vaccines